Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
暂无分享,去创建一个
C. Overall | E. Tam | C. McCulloch | J. Gong | I Clark-Lewis | C A McCulloch | C M Overall | G A McQuibban | J H Gong | E M Tam | G. A. McQuibban | G. McQuibban | I. Clark‐Lewis
[1] P. Proost,et al. The role of CD26/DPP IV in chemokine processing. , 1999, Chemical immunology.
[2] J. Reynolds,et al. Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. , 1994, The Biochemical journal.
[3] G. Opdenakker,et al. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. , 1993, Biochemical and biophysical research communications.
[4] C. López-Otín,et al. The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. , 1996, Journal of molecular biology.
[5] E. Howard,et al. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. , 1991, The Journal of biological chemistry.
[6] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[7] M. Stack,et al. A Plasma Membrane-associated Component of Ovarian Adenocarcinoma Cells Enhances the Catalytic Efficiency of Matrix Metalloproteinase-2 (*) , 1995, The Journal of Biological Chemistry.
[8] Anita B. Roberts,et al. REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .
[9] A. H. Drummond,et al. Processing of tumour necrosis factor-α precursor by metalloproteinases , 1994, Nature.
[10] C. Overall,et al. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen , 1995, The Journal of Biological Chemistry.
[11] H. Birkedal‐Hansen,et al. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). , 1993, Biochemistry.
[12] M. Cockett,et al. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A. , 1994, Biochemistry.
[13] S. Fields,et al. A novel genetic system to detect proteinprotein interactions , 1989, Nature.
[14] J. Wrana,et al. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. , 1991, The Journal of biological chemistry.
[15] G. Opdenakker,et al. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. , 1991, Lymphokine and cytokine research.
[16] J. Gong,et al. Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues , 1995, Journal of Experimental Medicine.
[17] B. Dewald,et al. RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors (*) , 1996, The Journal of Biological Chemistry.
[18] L. Matrisian,et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.
[19] C. Overall,et al. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. , 1990, The Journal of biological chemistry.